View Document Preview and Link Document Date: 2015-05-08 09:19:47 Open Document File Size: 215,56 KB Share Result on Facebook
City Atlanta / Milan / / Company M.E. Villarino A.S. / New England Journal / Sanofi Group / Lepetit Research Laboratories / / Country United States / Italy / South Africa / / Currency USD / / Event FDA Phase / / IndustryTerm offer products / manufacturing facilities / treatment solutions / healthcare personnel / pharmaceutical / / MedicalCondition Latent Tuberculosis Infection / bacterium Mycobacterium tuberculosis / Actions Tuberculosis / TB / contagious disease / malaria / Mycobacterium tuberculosis / M. tuberculosis Infection / drug-susceptible tuberculosis / latent TB infection / widespread infectious diseases / HIV/AIDS / tuberculosis / / MedicalTreatment antibiotics / / Organization Melinda Gates Foundation / World Health Organization / civil society / US Food and Drug Administration / Nelson Mandela Foundation / TB Alliance / Ministry of Health / U.S. Centers for Disease Control and Prevention / / Product Isoniazid / Sanofi / / PublishedMedium New England Journal of Medicine / / URL http / SocialTag 
FIGHTING TUBERCULOSIS BACKGROUND Along with HIV/AIDS and malaria, tuberculosis (TB) is one of the most widespread infectious diseases in the world. This contagious disease, caused by the bacterium Mycobacterium